2026-11-20 · BRAND GLP-1 · TopGLP1Providers Data Desk
What does brand Zepbound or Wegovy cost through a telehealth platform?
As of November 20, 2026, a telehealth platform adds its own fee to the manufacturer’s self-pay price. A year of brand Zepbound on the label’s dose path costs about $5,637 bought from LillyDirect with your own prescriber, about $6,225 through Mochi Health on its 12-month membership and about $7,315 through LifeMD, whose fee is $149 a month.
Released · Last reviewed · how we verify
Takeaway: the manufacturer’s price is the same through every route; what changes is the platform’s own fee, which adds $588 to $2,388 to a year of medication among the platforms whose fee we could read.
What changed in the first week of November
On November 6, 2026, Eli Lilly and Hims & Hers said in a joint release that Hims patients with a prescription from a licensed provider can buy Zepbound and Foundayo “at the same self-pay prices available to any patient” without leaving the Hims platform. The release puts the starting prices at $299 a month for Zepbound and $149 for Foundayo. It does not give a Hims membership fee, a start date or the dispensing pharmacy, and Hims says it has never offered compounded copies of Lilly’s drugs and will not.
A day earlier, LifeMD said its affiliated mail-order pharmacy would dispense and ship Zepbound and Foundayo at Lilly’s self-pay prices to patients prescribed by LifeMD-affiliated clinicians. We read that release through a syndicated copy, so treat it as reported: Lilly’s own site did not confirm it, and lilly.com refused our automated reads on November 20.
Neither announcement changes what Zepbound costs. Both move brand tirzepatide inside a subscription, which adds a second bill. That second bill is what this page measures.
The manufacturer price is the floor
Lilly sells Zepbound vials by dose. The prices below are the ladder we last read on October 15, 2026; Lilly’s November 6 release confirms the $299 starting price, and NovoCare’s Wegovy prices were read on November 20. No platform we read advertised the medication below the manufacturer’s self-pay price, so treat these as the floor for a brand month without insurance.
| Medication | Dose | Self-pay price | Condition |
|---|---|---|---|
| Zepbound vial (LillyDirect) | 2.5 mg | $299 | per fill |
| Zepbound vial (LillyDirect) | 5 mg | $399 | per fill |
| Zepbound vial (LillyDirect) | 7.5–15 mg | $449 | each refill within 45 days; otherwise $499 (7.5 mg) or $699 (10–15 mg) |
| Wegovy pen (NovoCare) | 0.25–2.4 mg | $349 | new patients: $199 for each of the first two fills of 0.25 or 0.5 mg through December 31, 2026 |
| Wegovy HD pen (NovoCare) | 7.2 mg | $399 | per month |
| Wegovy pill (NovoCare) | 1.5 / 4 / 9 and 25 mg | $149 / $199 / $299 | per month |
| Foundayo (LillyDirect) | from 0.8 mg | from $149 | 2.5 and 5.5 mg temporarily reduced through December 31, 2026 |
A vial or pen fill covers four weekly doses, so a year of treatment takes 13 fills, not 12. On the label’s schedule the dose starts at 2.5 mg for four weeks and rises by 2.5 mg every four weeks as tolerated. Priced that way, with every refill inside Lilly’s 45-day window, a year of Zepbound costs $299 + $399 + 11 × $449 = $5,637. If a refill slips past 45 days, the 10 mg fill costs $699 instead of $449, so one late refill adds $250.
The same arithmetic for Wegovy pens bought from NovoCare: two new-patient fills at $199, then 11 fills at $349, comes to $4,237. The new-patient price runs through December 31, 2026, so anyone starting in January should expect $349 from the first fill unless Novo Nordisk extends it.
What each platform adds
We read each platform’s own pricing page on November 20, 2026 and recorded its fee, how often it is charged and whether medication is included. None of these fees includes brand medication; each platform either sells the drug at the manufacturer’s price or sends you to buy it separately.
| Platform | Fee | Billed | What the page says about medication |
|---|---|---|---|
| LifeMD | $149 program and provider fee; $39 first month | monthly | Zepbound vial “starting at $299” and Wegovy pen “starting at just $199”; the fee is not included |
| Mochi Health | $79 membership, or $49 on a 12-month plan; first month free on the 1-month plan | monthly | Zepbound “as low as $299”, Wegovy injection $199 at starting doses for new patients, Foundayo and Wegovy pill from $149 |
| WeightWatchers Clinic | $74 a month on a 12-month plan or $84 on a 6-month plan, after a $25 first month | monthly, for the plan term | “Cost of GLP-1 medications not included.” |
| Sesame Care | $59 a month on an annual plan; $99 month to month | monthly | care only; medication not included |
| Calibrate | $199 a month, 3-month commitment | monthly | “Lab tests and prescription medications are not included” |
| PlushCare | $129 initial visit plus a $19.99 membership | interval not stated | medication not included in the fee |
| Hims & Hers | not published | — | Lilly says Hims patients pay Lilly’s self-pay prices; Hims’ page refused automated reads |
Two of these fees are not what they look like at first glance. WeightWatchers Clinic’s $74 is the 12-month price, so you are committing to a year of membership. Calibrate’s $199 comes with a three-month minimum and excludes lab tests. Ro, which has sold a brand-medication membership, refused our automated reads on November 20, so it is left out rather than shown with an old figure.
A year of brand Zepbound, platform by platform
Add each platform’s fee for 12 months to the $5,637 medication year. The chart and the table use the same figures; the medication part is identical in every row, so the differences are the fees alone.
Source: manufacturer and platform pages read November 20, 2026; Zepbound ladder carried from October 15, 2026 (lilly.com refused automated reads). Medication: $299 + $399 + 11 × $449. The axis starts at $0.
| Route | Medication | Platform fee | Year total | Fee basis |
|---|---|---|---|---|
| LillyDirect with your own prescriber | $5,637 | $0 | $5,637 | no platform fee; your clinician’s visit fees not counted |
| Mochi Health, 12-month membership | $5,637 | $588 | $6,225 | 12 × $49 |
| Sesame Care, annual plan | $5,637 | $708 | $6,345 | 12 × $59 |
| WeightWatchers Clinic, 12-month plan | $5,637 | $839 | $6,476 | $25 first month + 11 × $74 |
| Mochi Health, month to month | $5,637 | $869 | $6,506 | first month free (banner) + 11 × $79 |
| Sesame Care, month to month | $5,637 | $1,188 | $6,825 | 12 × $99 |
| LifeMD | $5,637 | $1,678 | $7,315 | $39 first month + 11 × $149 |
| Calibrate | $5,637 | $2,388 | $8,025 | 12 × $199; labs extra |
| Hims & Hers | $5,637 | — | — | fee not published; page refused automated reads |
The spread between the cheapest and the most expensive platform route is $1,800 a year, and all of it is service fees: Calibrate’s $2,388 against Mochi Health’s $588 on a 12-month plan. Buying direct from LillyDirect has no platform fee, but you need a prescriber, and a visit with your own clinician has its own cost that this table does not count.
For Wegovy, the same fees on a $4,237 medication year give $4,825 through Mochi Health’s 12-month plan, $4,945 through Sesame Care’s annual plan, $5,076 through WeightWatchers Clinic, $5,915 through LifeMD and $6,625 through Calibrate.
How brand routes compare with compounded programs
Compounded tirzepatide is a different product. It is not FDA-approved, it is made for an individual patient by a state-licensed pharmacy, and it is not the same as Zepbound. On prices read November 20, 2026, a year of compounded tirzepatide month to month costs $1,548 at NexLife or Eden ($129 a month), $1,512 at Mondae and about $1,027 at Collective once its $199 yearly membership is counted. Against the cheapest platform route for Zepbound, $6,225, the $1,548 year is $4,677 less.
What the brand price buys is FDA approval, the SURMOUNT trial evidence behind the label and manufacturer quality control. On November 9, FDA also required a new warning about NAION, a rare optic-nerve condition, on the labels of approved GLP-1 drugs, Zepbound and Foundayo included; FDA’s notice does not address compounded products. If cost is the main barrier, check insurance first: a covered prescription usually beats any cash route, though only 18% of firms with 200 or more workers cover GLP-1s for weight loss, according to KFF’s 2026 survey.
What to check before you subscribe
- The fee’s interval and term. A monthly price on a 12-month plan is a year’s commitment. Ask what cancelling early costs.
- The regular fee, not the first month. LifeMD’s $39 and WeightWatchers Clinic’s $25 apply once; budget the regular fee.
- Who ships the drug. Some platforms dispense through an affiliated pharmacy, others send you to LillyDirect or NovoCare. Either way the medication price should match the manufacturer’s.
- Refill timing. Lilly’s $449 price at 7.5 mg and above depends on refilling within 45 days. A platform’s scheduling cannot change that rule.
- Cancellation practice. The FTC, Utah and Los Angeles County sued Hims & Hers in July 2026 over subscription and cancellation practices; Hims has moved to dismiss, with a hearing set for January 14, 2027. The case is unresolved, but it is a reason to read any platform’s cancellation terms first.
What this means for you
If you already have a clinician willing to prescribe Zepbound or Wegovy, buying direct from LillyDirect or NovoCare is the lowest-cost brand route, because no platform fee is added. If you want a telehealth platform to handle prescribing and follow-up, the fee is the price of that service: about $588 to $2,388 a year among the platforms we could read. Compare the fee and its term, not the medication price, which is the same everywhere. Lilly and Novo Nordisk have not announced 2027 self-pay prices, so re-check in January.
Frequently asked
Does buying Zepbound through Hims & Hers or LifeMD cost more than LillyDirect?
The medication should cost the same: Lilly says Hims patients pay its self-pay prices, from $299 a month for Zepbound, and LifeMD says the same. What differs is the platform fee. LifeMD charges $149 a month after a $39 first month; Hims did not publish a fee in the release.
How much does a year of brand Zepbound cost without insurance?
About $5,637 bought direct on the label’s dose path: 13 four-week fills of $299, $399 and then 11 at $449, with each refill inside Lilly’s 45-day window (prices carried from October 15, 2026; the $299 start confirmed November 6). A platform fee is extra.
Which telehealth platform has the lowest fee for brand GLP-1 care?
Among the platforms whose page we could read on November 20, 2026, Mochi Health’s membership on a 12-month plan, $49 a month or $588 a year, is the lowest, followed by Sesame Care’s annual plan at $59 a month. Mochi’s month-to-month membership is $79.
Is compounded tirzepatide the same as Zepbound?
No. Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound; it is made for an individual patient by a state-licensed pharmacy. It costs less, $1,027 to $5,187 a year among programs we track that print a comparable price, but it has no FDA review of safety, effectiveness or quality.
Will Zepbound and Wegovy prices change in 2027?
Unknown. As of November 20, 2026, neither Lilly nor Novo Nordisk had announced 2027 self-pay prices. NovoCare’s $199 new-patient Wegovy offer and Lilly’s savings-card terms run to December 31, 2026, so check again in January.
Does Medicare cover brand GLP-1s bought through a platform?
The Medicare GLP-1 Bridge gives eligible Part D enrollees Foundayo, Wegovy or the Zepbound KwikPen (not vials) for a $50 monthly copay through December 31, 2027, under Medicare’s rules. A platform’s own fee is a separate charge; check whether the platform works with Part D.
Sources
- Lilly and Hims & Hers joint release (November 6, 2026; read November 20, 2026)
- NovoCare Pharmacy: Wegovy self-pay prices (read November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- FDA Drug Safety Communication: safety labeling changes for GLP-1 receptor agonists (NAION) (November 9, 2026; read November 20, 2026)
- Hims & Hers Form 10-Q for the quarter ended September 30, 2026 (SEC) (filed November 9, 2026; read November 20, 2026)
- Medicare.gov: weight-loss drugs and the Medicare GLP-1 Bridge (read November 20, 2026)
- LifeMD pricing page (read November 20, 2026)
- Mochi Health pricing page (read November 20, 2026)
- WeightWatchers Clinic pricing page (read November 20, 2026)
- Sesame Care pricing page (read November 20, 2026)
- Calibrate pricing page (read November 20, 2026)
- PlushCare pricing page (read November 20, 2026)
- NexLife tirzepatide plans page (read November 20, 2026)